Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (121-130 of 715) with videos related to

Pageof 72
Sort By:
Haemostasis|January 1, 1986
[Tissue plasminogen activator: mechanism of action and thrombolytic properties]D Collen, H R Lijnen
Annales De Biologie Clinique|January 1, 1987
Tissue-type plasminogen activatorH R Lijnen, D Collen
Thrombosis Research. Supplement|January 1, 1990
Measurement of plasminogen activator inhibitor 1 (PAI-1) in plasma with various monoclonal antibody-based enzyme-linked immunosorbent assaysP J Declerck, D Collen
Blood|December 15, 1991
Basic and clinical aspects of fibrinolysis and thrombolysisD Collen, H R Lijnen
Haemostasis|January 1, 1986
Molecular mechanisms of thrombolytic therapyH R Lijnen, D Collen
Haemostasis|January 1, 1986
[Molecular mechanisms of thrombolytic therapy]H R Lijnen, D Collen
Thrombosis Research|October 1, 1981
Degradation of the apoprotein A-I polypeptide chain of human high density lipoprotein by human plasminH R Lijnen, D Collen
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|August 25, 2000
Molecular basis of thrombolytic therapyH R Lijnen, D Collen
The Journal of Biological Chemistry|November 10, 1981
Immunochemical characterization of a low affinity lysine binding site within plasminogenE F Plow, D Collen
Haemostasis|January 1, 1986
Tissue-type plasminogen activator. Mechanisms of action and thrombolytic propertiesD Collen, H R Lijnen
Pageof 72

Showing results (121-130 of 715) with videos related to

Sort By:
Pageof 72
Haemostasis|January 1, 1986
[Tissue plasminogen activator: mechanism of action and thrombolytic properties]D Collen, H R Lijnen
Annales De Biologie Clinique|January 1, 1987
Tissue-type plasminogen activatorH R Lijnen, D Collen
Thrombosis Research. Supplement|January 1, 1990
Measurement of plasminogen activator inhibitor 1 (PAI-1) in plasma with various monoclonal antibody-based enzyme-linked immunosorbent assaysP J Declerck, D Collen
Blood|December 15, 1991
Basic and clinical aspects of fibrinolysis and thrombolysisD Collen, H R Lijnen
Haemostasis|January 1, 1986
Molecular mechanisms of thrombolytic therapyH R Lijnen, D Collen
Haemostasis|January 1, 1986
[Molecular mechanisms of thrombolytic therapy]H R Lijnen, D Collen
Thrombosis Research|October 1, 1981
Degradation of the apoprotein A-I polypeptide chain of human high density lipoprotein by human plasminH R Lijnen, D Collen
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|August 25, 2000
Molecular basis of thrombolytic therapyH R Lijnen, D Collen
The Journal of Biological Chemistry|November 10, 1981
Immunochemical characterization of a low affinity lysine binding site within plasminogenE F Plow, D Collen
Haemostasis|January 1, 1986
Tissue-type plasminogen activator. Mechanisms of action and thrombolytic propertiesD Collen, H R Lijnen
Pageof 72